Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» alpelisib
alpelisib
Novartis' PI3K drug, already approved in breast cancer, nabs a speedy OK to treat ultra-rare condition
Endpoints
Wed, 04/6/22 - 12:01 pm
Novartis
alpelisib
FDA
RWE
real world evidence
PROs
ASCO 2019 day three
Pharmaforum
Sun, 06/2/19 - 01:09 pm
ASCO 2019
Merck
AstraZeneca
pancreatic cancer
Novartis
alpelisib
Roche
entrectinib
Novartis sheds light on liquid biopsies with SOLAR-1 analysis
Biopharma Dive
Fri, 12/7/18 - 12:03 pm
Novartis
alpelisib
breast cancer
liquid biopsy
Novartis wants to blaze a trail in breast cancer with PIK3 drug
Pharmaforum
Sun, 10/21/18 - 11:26 pm
Novartis
clinical trials
alpelisib
breast cancer
Good Phase III results for Novartis’ cancer drug (breast cancer)
GoinPharma
Sun, 08/26/18 - 12:05 pm
Novartis
clinical trials
breast cancer
BYL719
alpelisib